Progress in Pharmacotherapy for Obesity

JAMA. 2021 Jul 13;326(2):129-130. doi: 10.1001/jama.2021.9486.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Anti-Obesity Agents / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Gastric Inhibitory Polypeptide / therapeutic use*
  • Glucagon-Like Peptide-1 Receptor Agonists*
  • Glucagon-Like Peptides / therapeutic use*
  • Humans
  • Obesity / drug therapy*
  • Tirzepatide

Substances

  • Anti-Obesity Agents
  • semaglutide
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptides
  • Tirzepatide
  • Glucagon-Like Peptide-1 Receptor Agonists